Maintenance fees coming due

Abraxis Bioscience, LLC

10 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Dec 25, 2026. Unpaid by Jun 25, 2027, that one lapses early.

A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.

Patent	Title	Holder	Status	Fee due	Lapses if unpaid	Expires	Confidence
US 10,328,031	Methods of Treating Pancreatic Cancer Abraxis Bioscience, LLC In force Fee due Dec 25, 2026 Lapses if unpaid Jun 25, 2027 Term ends Mar 23, 2033 · High confidence	Abraxis Bioscience, LLC	In force	Dec 25, 2026	Jun 25, 2027	Term ends Mar 23, 2033	High confidence
US 9,091,697	Use of 2 Anti-Sparc Antibodies to Predict Response to Chemotherapy for Pancreatic Adenocarcinoma Abraxis Bioscience, LLC In force Fee due Jan 28, 2027 Lapses if unpaid Jul 28, 2027 Term ends May 31, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Jan 28, 2027	Jul 28, 2027	Term ends May 31, 2030	High confidence
US 10,413,531	Methods of Treating Bladder Cancer Abraxis Bioscience, LLC In force Fee due Mar 17, 2027 Lapses if unpaid Sep 17, 2027 Term ends Mar 13, 2034 · High confidence	Abraxis Bioscience, LLC	In force	Mar 17, 2027	Sep 17, 2027	Term ends Mar 13, 2034	High confidence
US 9,149,455	Methods of Treating Melanoma Abraxis Bioscience, LLC In force Fee due Apr 6, 2027 Lapses if unpaid Oct 6, 2027 Term ends Apr 9, 2033 · High confidence	Abraxis Bioscience, LLC	In force	Apr 6, 2027	Oct 6, 2027	Term ends Apr 9, 2033	High confidence
US 10,527,604	Methods of Assessing Suitability of Use of Pharmaceutical Compositions of Albumin and Paclitaxel Abraxis Bioscience, LLC In force Fee due Jul 7, 2027 Lapses if unpaid Jan 7, 2028 Term ends Apr 18, 2036 · High confidence	Abraxis Bioscience, LLC	In force	Jul 7, 2027	Jan 7, 2028	Term ends Apr 18, 2036	High confidence
US 10,555,912	Use of Polymeric Excipients for Lyophilization or Freezing of Particles Abraxis Bioscience, LLC In force Fee due Aug 11, 2027 Lapses if unpaid Feb 11, 2028 Ends no later than Dec 13, 2032 · Medium confidence	Abraxis Bioscience, LLC	In force	Aug 11, 2027	Feb 11, 2028	Ends no later than Dec 13, 2032	Medium confidence
US 9,295,733	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Fee due Sep 29, 2027 Lapses if unpaid Mar 29, 2028 Term ends Dec 7, 2029 · High confidence	Abraxis Bioscience, LLC	In force	Sep 29, 2027	Mar 29, 2028	Term ends Dec 7, 2029	High confidence
US 11,944,708	Methods of Treating Central Nervous System Disorders via Administration of Nanoparticles of an Mtor Inhibitor and an Albumin Abraxis Bioscience, LLC In force Fee due Oct 2, 2027 Lapses if unpaid Apr 3, 2028 Term ends Jan 3, 2040 · High confidence	Abraxis Bioscience, LLC	In force	Oct 2, 2027	Apr 3, 2028	Term ends Jan 3, 2040	High confidence
US 9,308,279	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Fee due Oct 12, 2027 Lapses if unpaid Apr 12, 2028 Term ends Feb 1, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Oct 12, 2027	Apr 12, 2028	Term ends Feb 1, 2030	High confidence
US 9,314,537	Sparc Binding Scfvs Abraxis Bioscience, LLC In force Fee due Oct 19, 2027 Lapses if unpaid Apr 19, 2028 Term ends Feb 8, 2030 · High confidence	Abraxis Bioscience, LLC	In force	Oct 19, 2027	Apr 19, 2028	Term ends Feb 8, 2030	High confidence

10 of 10 patents shown. Soonest fee due date first, then patent number.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.